Interventional Pulmonology Seeks Better Outcomes for Lung Patients

by U.S. Medicine

July 12, 2012

By Stephen Spotswood

HOUSTON — Patients with lung cancer or other diseases where tumors are beginning to obstruct their central airway have a long, hard road ahead. As the tumor continues to grow, taking in oxygen becomes more and more difficult.

If the obstruction is left alone, shortness of breath worsens, and the prospect of more serious complications, such as post-obstructive pneumonia, increases. What usually follows is admission to the hospital for increasing doses of oxygen, treatment with antibiotics and sometimes even morphine to relieve  dyspnea.

At the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, physicians are honing the use of advanced, minimally invasive techniques to create better outcomes for these patients and avoid those long hospital stays.

In a photo from the Houston VA website, Roberto Casal, M.D. poses with patient Clara Traylor. Photo by Quentin Melson, Public Affairs Specialist

Better Diagnostic Techniques

A relatively new field, interventional pulmonology  uses advanced diagnostic and therapeutic tools to manage patients with lung cancer and other diseases that block central airways.

Left untreated, obstructions, “leave patients with no quality of life whatsoever and keeps them away from their loved ones,” explained Roberto Casal, MD, MEDVAMC’s Bronchology Lab director and the physician spearheading the hospital’s interventional pulmonology (IP) efforts.

Casal came to MEDVAMC from the MD Anderson Cancer Center, which prepared him for dealing with aggressive lung cancer cases. “Training at MD Anderson was a perfect match for my job at the MEDVAMC,” he said. “Unfortunately, most cases I see are of malignant origin. That training has given me the knowledge and experience I need to deal with these cases.”

Dealing with these cases involves employing varying techniques to better examine tumors and to unblock airways and allow patients to breathe on their own.

One procedure with  the biggest impact to the department in recent years is the use of endobronchial ultrasound (EBUS). A bronchoscope with an ultrasound transducer at the tip is used to take biopsies from areas near the patient’s windpipe.

“EBUS allows us to accurately and safely sample any mediatinal structure, particularly lymph nodes,” Casal said. “EBUS has rapidly replaced mediastinoscopy for staging of lung cancer in centers with high EBUS expertise, such as ours. Not only are we avoiding a more invasive and surgical procedure, but we are reducing the absolute number of invasive procedures required for diagnosis and staging of lung cancer.”

Interventional Pulmonology Seeks Better Outcomes for Lung Patients

This reduces risk, time and possibly cost to the hospital. Considering that the patients benefiting from this technique tend to be older and have other comorbidities, the less time they spend in surgery, the less chance of complications.

Another advanced diagnostic tool being used at MEDVAMC is electromagnetic navigational bronchoscopy (EMN), a system which allows physicians to better navigate through airways and obtain samples from small peripheral lung nodules they otherwise could not reach.

Therapeutic Bronchoscopy

A third of patients with lung cancer will develop obstructions at some point, and a third of these patients will die from that. Other cancers can spread to the airways or compress the airways from the outside. For treating these patients, the IP clinic can choose from several therapeutic bronchoscopic procedures.

 “In the last couple of years, we have assembled an interventional bronchoscopy suite with the highest available technology in the field,” Casal said. “And we have a dedicated general anesthesia team, which allows us to perform any procedure without using the [general] OR. With a combination of techniques, we can remove the endoluminal component of any tumor that invades the central airways. We also have the capability of placing any kind of airway stent. This allows us to better customize the treatment to each one of our patients.”

Casal has received extensive training in several techniques, some of which are argon plasma coagulation (applying heat by electronic current) cryotherapy (freezing the cancerous tissue), microdebrider (using rotating blades to cut the tumor), LASER bronchoscopy (using a laser on the tumor). Casal can use one or a combination of these techniques on a patient, depending on the circumstances.

“Before the establishment of our IP service, most patients with central airway obstructions were either treated with radiation therapy, continued to receive chemotherapy, were considered hospice care patients or were referred to an outside facility, typically MD Anderson Cancer Center,” Casal said. “The effectiveness of radiation and chemotherapy for this condition is low, since most patients have already failed to respond.”

In the last two years, Casal and his colleagues have performed 120 therapeutic bronchoscopies at MEDVAMC. Casal noted that the impact of therapeutic bronchoscopy on patient survival is unknown, but there is no doubt it is successful in improving patients’ quality of life. 

The services the IP clinic provides are still relatively unknown to the rest of the field, however.

“The main problem I face is the lack of awareness about our service and about the possibility of helping these patients with central airway obstruction,” Casal said. “Unfortunately, I am getting many of these patients when it is already too late.”

Michael E. DeBakey VA Medical Center – Houston, Texas

Back to July Articles

Related Articles

New Agents Extend Options for Increased Survival in Metastatic Prostate Cancer

Accounting for nearly a third of all cancer diagnoses, prostate cancer is the most frequently diagnosed cancer in the VHA, where past research has suggested that the malignancy is caught earlier than in other healthcare systems.

Personalized Medicine Brightens Outlook for Most Common Kidney Cancer

In the past five years, 10 new system therapies have been approved for renal cell carcinoma (RCC), the most common type of kidney cancer.

U.S. Medicine Recommends

More From department of veterans affairs

Department of Veterans Affairs (VA)

Bill to Streamline, Expand VA’s Choice Program Signed Into Law

Legislation that would streamline VA’s community care programs into one program and expand VA’s caregiver program to veterans of all eras was signed into law earlier this month..

Department of Veterans Affairs (VA)

Despite Criticism, VA Healthcare as Good or Better Than Other Systems

The good news from a recent consultant study is that, overall, the VA healthcare system is generally equal or better than others when inpatient and outpatient quality is measured.

Department of Veterans Affairs (VA)

VA Inks Contract for Massive New Health Record System

Calling it one of the largest IT contracts in the federal government, with a ceiling of $10 billion over a decade, then-VA Acting Secretary Robert Wilkie announced that the agency signed a contract with Cerner for its new electronic health record (EHR).

Department of Veterans Affairs (VA)

Surprise! President Nominates Wilkie for Permanent VA Secretary

President Donald Trump said last month that acting VA Secretary Robert Wilkie “has done an incredible job” and, in a surprise move, nominated him for the permanent Cabinet position.

Department of Veterans Affairs (VA)

Fibromyalgia Presents Differently in Male, Female Veterans

Research on fibromyalgia, a poorly understood, chronically disabling pain syndrome, generally has focused on its clinical presentation and treatment.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up